Some news from the COVID19 vaccine race

With more than 165 vaccine candidates around the world, it is not always easy to keep track of the progresses made along the vaccine testing process. Recently, communications were made about 3 candidate vaccines which entered the phase III clinical trial: the Pfizer and BioNTech, the Moderna and the ChAdOx1 nCoV-19 candidates. There are currently 6 candidate vaccines at this late-stage human trial and one vaccine approved for limited use in China.

Links: Pfizer and BioNTech; ChAdOx1 nCoV-19; Moderna

Keeping track: https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html